← Back
$TSHA All transactions

Taysha Gene Therapies, Inc.

▼ SELL

$ Value

$163K

Shares

57,054

Price

$3

Filed

Aug 22

Insider

Name

Nagendran Sukumar

Title

President and Head of R&D

CIK

0001665124

Roles

Director Officer

Transaction Details

Transaction Date

2025-08-21

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,165,289

Footnotes

Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.841 to $2.865 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001415889-25-022750

Form Type

4

Issuer CIK

0001806310

Nagendran Sukumar's History

Date Ticker Type Value
2026-04-10 TSHA M $33K
2026-04-10 TSHA $892K
2026-04-10 TSHA M $0
2026-01-26 TSHA $124K
2026-01-23 TSHA $423K
2026-01-12 TSHA M $78K
2026-01-12 TSHA M $152K
2026-01-12 TSHA $942K
2026-01-12 TSHA A $0
2026-01-12 TSHA M $0

Other Insiders at TSHA (90d)

Insider Bought Sold Last
Nolan Sean P.
Chief Executive Officer
$840K 2026-01-26
Nagendran Sukumar
President and Head of R&D
$1.4M 2026-04-10
Alam Kamran
CHIEF FINANCIAL OFFICER
$493K 2026-02-04